Semaglutide Supply Update: What You Need to Know Before May 22‍

If you’re currently using compounded Semaglutide for weight loss, there’s an important update that may impact your care. Due to updated guidance from the U.S. Food and Drug Administration (FDA), pharmacies will no longer be permitted to produce compounded Semaglutide injections after May 22, 2025.

Here’s what’s changing—and how to prepare for a smooth transition.

Why is This Happening?

Compounding pharmacies are only permitted to create custom versions of medications when the brand-name version is in short supply. This has included GLP-1 medications like Ozempic® and Wegovy®, which contain Semaglutide.

Now that the FDA has removed Semaglutide from the national shortage list, all U.S. compounding pharmacies must stop producing compounded Semaglutide injections by May 22, 2025.

This means:

• All US compounding pharmacies must stop producing Semaglutide injections
• Remaining inventory will be limited
• New prescriptions must be submitted before May 22 to be eligible for fulfillment

Why This Matters For You

To date, compounded Semaglutide injections have offered a more accessible and affordable option for many individuals—especially those whose insurance didn’t cover brand-name GLP-1s. It has helped thousands of people access safe, medically guided weight loss care during a time of high demand and limited supply.

With compounded injectable Semaglutide no longer available, you may need to adjust your treatment plan to avoid a gap in care.

What You Can Do Now

To ensure continuity of care, we strongly recommend ordering a 3- or 6-month plan before May 19 to guarantee fulfillment — plans start at $285/month*

Switch to a multi-month plan today:

• Existing customers: Upgrade directly in your Alan Portal
• New customers: Sign up and start your consultation here

Where Your Medication Comes From

Alan Health works with trusted, federally regulated 503B pharmacies, including Olympia and BPI, to ensure your medications are safe and high quality. These pharmacies follow strict FDA guidelines and undergo regular inspections to maintain sterile environments and consistent standards. Your compounded prescriptions are made in facilities held to the highest level of oversight and care.

Explore Alternative Options

Alan Health offers seamless support to help you transition to alternative weight loss offerings confidently. Available alternatives include:

• FDA-approved GLP-1 medications (Ozempic®, Wegovy®, Mounjaro®, Zepbound®)
• Oral compounded GLP-1s
• Non-GLP-1 options, including Bupropion/Naltrexone/B12

If you're unsure what this means for your care, your Alan Health provider or support team is here to help guide the transition. Our providers are here to help you find the right fit for your goals and budget.

Alan Health also offers supplement support and expert guidance to help you feel your best—no matter which treatment path you take.

Frequently Asked Questions

• Why are compounded Semaglutide injections being discontinued?‍
  • The FDA has determined that compounded versions are no longer permitted now that there is adequate commercial supply.

• ‍Can I still order compounded Semaglutide?‍
  • Only individuals who order before May 19, 2025 are guaranteed to receive a compounded supply. We’re offering discounted 3- and 6-month plans to support continuity of care. Existing customers can upgrade directly in their Alan portal, and new customers can sign up here.

• ‍Who are your pharmacy partners?‍
  • Alan Health partners with federally regulated 503B pharmacies, including Olympia and BPI, which are registered with the FDA and held to strict safety and quality standards. These facilities are routinely inspected and follow sterile compounding protocols to ensure your medication is made in a controlled, high-quality environment. You can feel confident knowing your prescription is produced with care and oversight.

• ‍What are my options now?‍
  • You can speak with your provider about switching to a highly-effective alternative weight loss program, including brand-name GLP-1 medication or considering other options such as oral compounded GLP-1s or non-GLP-1 alternatives. 

• ‍I have a prescription but haven’t received it yet — will it ship?
  • ‍Orders placed and accepted by a pharmacy before May 22 may still be fulfilled, depending on inventory and processing timelines.

• ‍What are my next steps if I can’t get compounded Semaglutide injections?‍
  • Talk to your Alan provider about switching to a brand-name option or other medically appropriate alternatives via your portal.

We’re Here to Help‍

If you have questions about your treatment plan or want to explore next steps, contact us at help@alanmeds.com or message your provider directly via your portal.

We’re here to support your weight loss journey—every step of the way.

‍